The John Mendelsohn Page

John Mendelsohn biography: Harvard Medical School MD 1963 (after a year in Scotland as a Fulbright Scholar); research associate at the National Institutes of Health; instructor in medicine at Washington University in St. Louis; faculty of the University of California - San Diego 1970-1985; chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center 1985-1996; successor of anti-smoking kingpin Charles A. LeMaistre as president of the MD Anderson Cancer Center, 1996-present; Board of Director and Medical Advisory Board of ImClone Systems Inc. 1998-present; director of Enron Corp. 1999-2001; Medical Advisory Board of the Breast Cancer Research Foundation.

Mendelsohn bio / University of Texas
Medical Advisory Board / Breast Cancer Research Foundation

Mendelsohn was a member of the 2000 National Cancer Policy Board, chaired by former Council for Tobacco Research Scientific Advisory Board member Peter M. Howley, which produced the report "State Programs Can Reduce Tobacco Use." It was reviewed by a panel of leading anti-smokers who are notable for their psychopathology, including Frank J. Chaloupka, Stanton A. Glantz, Thomas P. Houston, and Mathew Myers. Other members of the NCPB include John Seffrin of the American Cancer Society, and Lawrence O. Gostin, main author of the Model Emergency Health Powers Act scheme to eliminate civil liberties under the pretext of ill-defined health emergencies.

National Cancer Policy Board / National Academy Press 2000

Mendelsohn was said "to have links to the Bush family" and was rumored to have been a possible candidate for Director of the National Institutes of Health in 2001. (Texan to head NIH? By Jocelyn Kaiser. Science Now Jan 9 2001.)

Kaiser, Science 2001 / Biological Research Information Center, Korea

ACS "National Dialog on Cancer"

Mendelsohn is a member of the American Cancer Society's ill-named "National Dialog on Cancer," which also includes Mohammed Akhter of the APHA, Vincent T. DeVita, Sam Donaldson of ABC, President's Cancer Panel fixture Harold P. Freeman, Sen. Bill Frist, NIH Director Julie Gerberding, LaSalle D. Leffall Jr., Charles A. LeMaistre, Alan S. Rabson of the NCI (former acting NIH Diector Ruth Kirschstein's husband), former CDC Director William Roper, and John R. Seffrin of the ACS.

NDOC Partners / National Dialog on Cancer

ImClone Systems Inc.

The EGF receptor family as targets for cancer therapy. J Mendelsohn, J Baselga. Oncogene 2000 Dec 27;19(56):6550-6565. Mendelsohn's paper on IMC-C225, aka Erbitux. The company is accused of misrepresenting the drug's chances of approval by the Food and Drug Administration. It was supposed to have been a magic bullet for colon cancer. Founder Sam Waksal's father and daughter, and celebrity investor Martha Stewart sold their stock in the company just before the FDA's denial of the drug's approval.

Mendelsohn - Oncogene 2000 abstract / PubMed

The ImClone Systems 2002 Board of Directors includes Robert F. Goldhammer, 1988-89 managing director of Kidder, Peabody; Andrew G. Bodnar of Bristol Myers Squibb (which in 2001 became the largest stockholder in ImClone); Vincent T. DeVita Jr., director of the National Cancer Institute from 1980 to 1988 (a correspondent of Mary Lasker from 1981-88 and recipient of a Lasker Award in 1982), at Memorial Sloan Kettering Cancer Institute from 1988 to 1995, professor of Medicine and professor of Epidemiology at Yale University; David M. Kies, a partner of Sullivan & Cromwell; Paul B. Kopperl, associate with Goldman, Sachs from 1959-67 and vice president of Kidder, Peabody from 1967-75; Arnold J. Levine of The Rockefeller University; John Mendelsohn; William R. Miller, fomer vice president of Bristol Myers Squibb; and founder Harlan W. Waksal.

Board of Directors / ImClone Systems

Samuel D. Waksal, Harlan W. Waksal, and Robert F. Goldhammer have been the largest individual shareholders of ImClone. In 2001 FMR (Fidelity Mutual Research, the Boston firm that is also the largest shareholder in Philip Morris and in the anti-smoking Brown Shoe Corp.) held 14.7% of shares; in 2002 Bristol Myers Squibb held 19.63% and FMR Group held 14.90%.

1997 ImClone DEF14A / SEC
1998 ImClone DEF14A / SEC
2000 ImClone DEF14A / SEC
2001 ImClone DEF14A / SEC
2002 ImClone DEF14A / SEC

The Waksals and Mendelsohn are listed in the 2002 edition of Genetic Engineering News' 100 Molecular Millionaires. Samuel D. Waksal, $122,943,676; Harlan W. Waksal, $98,714,317, and John Mendelsohn, $12,356,531. First on the list is Lindsay Rosenwald, a son-in-law of Research!America director J. Morton Davis, $617,421,671. Lasker crony Gilbert S. Omenn made the list with $18,977,709.

2002 Molecular Millionaires / Genetic Engineering News

(The Cancer Letter's Goldberg delves into the details, by Michael Barbaro. The Washington Post 2002 Aug. 5, p. E01.) "The angle he wants to see back in the headlines is not who traded on secret FDA information, but how and why cancer patients were subjected to a poorly designed regimen..."

Barbaro / Washington Post 2002

"Cancer crusader weathers scandals," by Leigh Hopper, Houston Chronical Medical Writer. Houston Chronicle, March 30, 2003.

Hopper, March 30, 2003 / Houston Chronicle

National Coalition on Health Care

Mendelsohn is a supporter of the National Coalition on Health Care. The NCHC is an umbrella group that breaks the mold of K Street lobbyists by being located on G Street instead. Former Rep. Paul G. Rogers is co-chair with the former governor of Iowa. Members of the board of directors include Rogers; Frank Carlucci of the Carlyle Group, also on the board of the Rand Corporation; and William Novelli, chairman of the board and former president of the ACS & RWJF-funded Campaign for Tobacco-Free Kids, who is now Executive Director and President of the AARP. Individual supporters include Robert N. Butler; former AHF Trustees Charles C. Edwards and Edmund D. Pellegrino; Roz Lasker's "Medicine and Public Health" crony, M. David Low; University of Michigan Vice President for Health Gilbert S. Omenn; former Secretary of the Department of Health and Human Services Louis Sullivan; and Laurance Rockefeller.

Supporters / National Coalition on Health Care

Health Fascism Promotion

"When MD Anderson initiated its wellness program, president John Mendelsohn took walks throughout the building with wellness coach Bill Baun. For many, it was the first time the president had been in their work space or had shaken their hand, and he tended to start conversations with 'How’s your wellness?'" (What’s the Hard Return on Employee Wellness Programs? By LL Berry, AM Mirabito, WB Baun. Harvard Business Review 2010 Dec). There is actually no hard data here whatsoever, and nothing on methodology. The reader is expected to believe the claims of fanatical ideologues on pure faith. It's a window into the sheer incompetence and the culture of herd belief of the elite business establishment. Its first author, Leonard Berry, is in fact a huckster from the Department of Marketing at Texas A&M.

Berry 2010 / Social Science Research Network

Samuel D. Waksal

"In 1984 he founded ImClone, a little-known company until it made headlines for an apparent success with a cancer treatment called Erbitux in 1999. Waksal, 54, was always as much salesman as scientist and employed his reputation and charm as a ladder into elite circles that included home-decor guru [Martha] Stewart, Mick Jagger, actress Mariel Hemingway, financier Carl Icahn and Dr. John Mendelsohn, the cancer drug pioneer and former Enron board member." (Sam's Club. By Daniel Kadlec. Time Jun 17 2002.)

Kadlec / Time 2002

"Sam Waksal is the former head of ImClone. He comes out of Manhattan dinner parties where misrepresenting yourself is part of an introduction, and the table is full of lobster mousse and suckers who cannot wait to be taken... 'Bristol-Myers had dominated the oncology with taxol. That was ending. They were desperate. Then here was Waksal with his ability to get so many social favors. They thought he could deliver the FDA over another dinner." (Making money on cancer. By Jimmy Breslin. Newsday June 30, 2002.)

Breslin / Newsday 2002

"In Manhattan and its environs, friendships such as theirs often coincide with business relationships. And where power, success, and social advantage intersect, information that most people might think is exceedingly privileged is passed at cocktail parties and over linen-clad dinner tables as casually as canapes... Those observations are traded by a group as old-fashioned and exclusive as the 400 well-to-do New Yorkers who could fit into Mrs. William Sackhouse Astor's ballroom in the 19th century." (Social climbing via stock tips. By Alex Kuczynski and Andrew Ross Sorkin. The New York Times July 2 2002/The International Herald Tribune.)

Kuczynski & Sorkin / International Herald Tribune 2002


cast 11-23-12